R. Keith Woods

R. Keith Woods has served as Chief Operating Officer of Scholar Rock since April 2025. He has over three decades of experience in the biopharmaceutical industry, having served most recently as Chief Operating Officer of argenx Pharmaceuticals, where he led the company through its transition from an R&D organization to become a fully integrated global biopharmaceutical organization. During this time, Keith oversaw key teams in preparation for argenx’s first product launch, including sales, marketing, market access and reimbursement, business operations, patient services and medical affairs. In 2023, he transitioned from this role to serve as a strategic commercial advisor to the board of directors of argenx.

Prior to argenx, Keith served as senior vice president of North American operations for Alexion Pharmaceuticals, Inc., where he managed a team of several hundred people in the U.S. and Canada. Additionally, within his tenure at Alexion, he served as vice president and managing director of Alexion UK, overseeing all aspects of Alexion’s UK business. Previously, he held various positions of increasing responsibility within Roche, Amgen, and Eisai Co., Ltd., over a span of 20 years.

Keith currently serves on the board of directors of Neurogene Inc. and TScan Therapeutics, Inc.  He holds a Bachelor of Science in marketing from Florida State University.